A single-centre retrospective observational case series evaluating prognostic significance of macular capillary drop-out and previous panretinal laser photocoagulation in treatment-naive patients with diabetic macular oedema treated with intravitreal ranibizumab.
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 14 Oct 2016 New trial record